Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Stopped early · Phase 2
Conditions studied: Multiple Myeloma
In brief
The goal of this clinical study is to learn more about the safety and dosing of the study drug, magrolimab, in combination with other anticancer therapies in participants with relapsed/refractory multiple myeloma.
Key facts
- Study ID
- NCT04892446
- Run by
- Gilead Sciences
- People needed
- 36
- Starts
- 2021-11-09
- Expected to finish
- 2024-04-25
- Last updated by the study team
- 2025-05-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Arizona Oncology Associates , PC - HOPE — Tucson, Arizona, United States
- US San Diego Moores Cancer Center — La Jolla, California, United States
- Stanford Cancer Institute — Palo Alto, California, United States
- Karmanos Cancer Institute — Detroit, Michigan, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center - Main Campus — New York, New York, United States
- Levine Cancer Institute — Charlotte, North Carolina, United States
- Duke University — Durham, North Carolina, United States
- Cleveland Clinic - Taussig Cancer Institute — Cleveland, Ohio, United States
- The Ohio State University — Columbus, Ohio, United States
- Hightower Clinical — Oklahoma City, Oklahoma, United States
- Bend Memorial Clinic, P.C. d/b/a Summit Health — Bend, Oregon, United States
- Oregon Health and Science University — Portland, Oregon, United States
- US Oncology, Inc. IRB — Dallas, Texas, United States
- Huntsman Cancer Institute — Salt Lake City, Utah, United States
- US Oncology, Inc., IRB — Fairfax, Virginia, United States
- Cross Cancer Institute — Edmonton, Canada
- Princess Margaret Cancer Centre — Toronto, Canada
- Fakultní nemocnice Brno — Brno, Czechia
- Fakultní Nemocnice Olomouc — Olomouc, Czechia
- Vseobecna fakultni nemocnice v Praze — Prague, Czechia
- Fakultní nemocnice Ostrava — Severomoravsky KRAJ, Czechia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.